HAEK.DE
Price:
$21.4
Market Cap:
$111.50M
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-28
Stock Exchange
XETRA
Ticker
HAEK.DE
According to HAEMATO AG’s latest financial reports and current stock price. The company's current PE Ratio is 11.57. This represents a change of -427.81% compared to the average of -3.53 of the last 4 quarters.
The mean historical PE Ratio of HAEMATO AG over the last ten years is 3.55. The current 11.57 PE Ratio has changed 32.45% with respect to the historical average. Over the past ten years (40 quarters), HAEK.DE's PE Ratio was at its highest in in the June 2022 quarter at 31.85. The PE Ratio was at its lowest in in the December 2021 quarter at -62.01.
Average
3.55
Median
12.31
Minimum
-57.68
Maximum
19.14
Discovering the peaks and valleys of HAEMATO AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 113.78%
Maximum Annual PE Ratio = 19.14
Minimum Annual Increase = -442.10%
Minimum Annual PE Ratio = -57.68
Year | PE Ratio | Change |
---|---|---|
2022 | 10.43 | -45.50% |
2021 | 19.14 | -184.90% |
2020 | -22.54 | -60.91% |
2019 | -57.68 | -442.10% |
2018 | 16.86 | 7.54% |
2017 | 15.68 | 29.39% |
2016 | 12.12 | -34.07% |
2015 | 18.38 | 47.04% |
2014 | 12.50 | 17.31% |
2013 | 10.66 | 113.78% |
The current PE Ratio of HAEMATO AG (HAEK.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.34
5-year avg
-6.76
10-year avg
3.55
HAEMATO AG’s PE Ratio is less than M1 Kliniken AG (16.27), less than NORMA Group SE (25.28), greater than Biofrontera AG (-0.50), less than Medios AG (23.99), less than Apontis Pharma AG (123.81),
Company | PE Ratio | Market cap |
---|---|---|
16.27 | $279.24M | |
25.28 | $371.52M | |
-0.50 | $20.67M | |
23.99 | $300.97M | |
123.81 | $93.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HAEMATO AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HAEMATO AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HAEMATO AG's PE Ratio?
How is the PE Ratio calculated for HAEMATO AG (HAEK.DE)?
What is the highest PE Ratio for HAEMATO AG (HAEK.DE)?
What is the 3-year average PE Ratio for HAEMATO AG (HAEK.DE)?
What is the 5-year average PE Ratio for HAEMATO AG (HAEK.DE)?
How does the current PE Ratio for HAEMATO AG (HAEK.DE) compare to its historical average?